Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
This statistic discloses the sales value of the French pharmaceutical group Ipsen in 2019, in million euros, by therapeutic area. The group achieved more than 1.8 billion euros of sales in the oncology category for the year 2019, while the sale of pharmaceutical products for neuroscience generated around 391 million euros.
Sales of the French pharmaceutical group Ipsen in 2019, by therapeutic area (in million euros)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Global revenue of the Ipsen group 2019, by geographical area
- Premium Statistic Commercial expenses of the Ipsen group 2014-2019
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Total assets of the Ipsen group 2014-2019
- Premium Statistic Global revenue in specialty medicine of the Ipsen group 2014-2019
- Premium Statistic Total equity of the Ipsen group 2014-2019
- Premium Statistic Global revenue in general medicine of the Ipsen group 2014-2019
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Research and development expenditure of the Ipsen group 2014-2019
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
About the region
10
- Basic Statistic Medication sales of the Ipsen Group 2019
- Premium Statistic Global revenue of the Ipsen group 2014-2019
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Premium Statistic Top global companies by orphan drug revenues 2023
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Basic Statistic Worldwide therapeutic licensing and acquisition deals share 2009-2018 by disease type
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2022
Selected statistics
5
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Basic Statistic U.S. venture funding of therapeutic companies by disease type 2023
- Basic Statistic Antibacterials for systemic use: consumption in Luxembourg 2022
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Scotland: distribution of population prescribed an antibiotic by age and gender 2022
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Biopharmaceutical revenues in Germany in 2022, by application field
- Basic Statistic Patented drug products annual sales in Canada 1990-2022
- Basic Statistic Leading pharmaceutical companies in Norway 2021, by revenue
- Basic Statistic Antibacterials for systemic use: consumption in Greece 2022
Related statistics
10
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Basic Statistic Breakdown of employees of drug companies by age France 2014
- Premium Statistic Boiron's stock price at the end of the year 2012-2022
- Premium Statistic Average full-time equivalent workforce of Boiron Laboratories 2012-2022
- Premium Statistic Cashflow of Boiron laboratories 2013-2022
- Premium Statistic Boiron laboratories' market capitalization at the end of the year 2012-2022
- Premium Statistic Personnel costs of Boiron laboratories 2012-2022
- Premium Statistic Workforce of Boiron laboratories in the World in 2022, by region
- Premium Statistic Distribution of the Boiron laboratories workforce in 2022, by world region
- Premium Statistic Boiron's capital breakdown at the end of 2022, by shareholder
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's ad spending 2006-2023
- GSK's operating profit by division 2006-2021
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- MorphoSys' revenue 2006-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's ad spending 2006-2023
- GSK's operating profit by division 2006-2021
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- MorphoSys' revenue 2006-2023
Ipsen. (February 13, 2020). Sales of the French pharmaceutical group Ipsen in 2019, by therapeutic area (in million euros) [Graph]. In Statista. Retrieved May 21, 2024, from https://www.statista.com/statistics/1072739/ipsen-sales-annual-field-therapeutic/
Ipsen. "Sales of the French pharmaceutical group Ipsen in 2019, by therapeutic area (in million euros)." Chart. February 13, 2020. Statista. Accessed May 21, 2024. https://www.statista.com/statistics/1072739/ipsen-sales-annual-field-therapeutic/
Ipsen. (2020). Sales of the French pharmaceutical group Ipsen in 2019, by therapeutic area (in million euros). Statista. Statista Inc.. Accessed: May 21, 2024. https://www.statista.com/statistics/1072739/ipsen-sales-annual-field-therapeutic/
Ipsen. "Sales of The French Pharmaceutical Group Ipsen in 2019, by Therapeutic Area (in Million Euros)." Statista, Statista Inc., 13 Feb 2020, https://www.statista.com/statistics/1072739/ipsen-sales-annual-field-therapeutic/
Ipsen, Sales of the French pharmaceutical group Ipsen in 2019, by therapeutic area (in million euros) Statista, https://www.statista.com/statistics/1072739/ipsen-sales-annual-field-therapeutic/ (last visited May 21, 2024)
Sales of the French pharmaceutical group Ipsen in 2019, by therapeutic area (in million euros) [Graph], Ipsen, February 13, 2020. [Online]. Available: https://www.statista.com/statistics/1072739/ipsen-sales-annual-field-therapeutic/